- Report
- November 2023
- 230 Pages
Global
From €2351EUR$2,583USD£1,997GBP
€3359EUR$3,690USD£2,853GBP
- Book
- October 2020
- 800 Pages
- Book
- April 2019
- 1008 Pages
- Book
- March 2015
- 512 Pages
- Book
- March 2009
- 278 Pages
- Book
- April 2024
North America
- Book
- February 2020
North America
- Book
- November 2018
North America

Ischemic stroke is a type of stroke that occurs when a blood clot blocks an artery supplying blood to the brain. It is the most common type of stroke, accounting for approximately 87% of all stroke cases. Ischemic stroke is a major cause of death and disability worldwide, and is a major public health concern.
The ischemic stroke market within the context of cardiology is a rapidly growing market, driven by the increasing prevalence of stroke, the growing geriatric population, and the increasing demand for advanced treatments. The market is expected to be driven by the increasing adoption of minimally invasive treatments, such as thrombolysis and thrombectomy, as well as the development of novel treatments, such as stem cell therapy.
Some of the key players in the ischemic stroke market include Medtronic, Stryker, Johnson & Johnson, Boston Scientific, Abbott, and Terumo. Show Less Read more